CBT
BIO icon

Capital Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capital Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed -$2K – 331
2020
Q1 		$2K Buy
+5
New +$1.84K ﹤0.01% 630
2019
Q2 		– Sell
-20
Closed -$6K – 678
2019
Q1 		$6K Buy
+20
New +$5.4K ﹤0.01% 573
2018
Q2 		– Sell
-100
Closed -$25K – 689
2018
Q1 		$25K Hold
100
– – ﹤0.01% 448
2017
Q4 		$24K Hold
100
– – ﹤0.01% 480
2017
Q3 		$22K Hold
100
– – ﹤0.01% 437
2017
Q2 		$23K Buy
+100
New +$21.8K ﹤0.01% 404

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Bank & Trust's BIO Position: Q2 2020 in Review

Capital Bank & Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 5 shares — an estimated $2K sold.

Capital Bank & Trust first reported a position in BIO in Q2 2017 and held it in 6 quarters. The position peaked at $25K in Q1 2018. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Capital Bank & Trust reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 5 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $2K.
  • Capital Bank & Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2017 and held it in 6 quarters.
  • Capital Bank & Trust's Bio-Rad Laboratories Class A position peaked at $25K in Q1 2018.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.